Kotsuji F - Search Results

1

Theophylline and cisplatin synergize in down regulation of BCL-2 induction of apoptosis in human granulosa cells transformed by a mutated p53 (p53 val135) and Ha-ras oncogene.

Yoshida Y, Hosokawa K, Dantes A, Tajima K, Kotsuji F, Amsterdam A. Yoshida Y, et al. Among authors: kotsuji f. Int J Oncol. 2000 Aug;17(2):227-35. doi: 10.3892/ijo.17.2.227. Int J Oncol. 2000. PMID: 10891529

2

Phosphodiesterase inhibitors as anti-cancer drugs.

Hirsh L, Dantes A, Suh BS, Yoshida Y, Hosokawa K, Tajima K, Kotsuji F, Merimsky O, Amsterdam A. Hirsh L, et al. Among authors: kotsuji f. Biochem Pharmacol. 2004 Sep 15;68(6):981-8. doi: 10.1016/j.bcp.2004.05.026. Biochem Pharmacol. 2004. PMID: 15313391

3

Steroid regulation during apoptosis of ovarian follicular cells.

Amsterdam A, Dantes A, Hosokawa K, Schere-Levy CP, Kotsuji F, Aharoni D. Amsterdam A, et al. Among authors: kotsuji f. Steroids. 1998 May-Jun;63(5-6):314-8. doi: 10.1016/s0039-128x(98)00016-6. Steroids. 1998. PMID: 9618793 Review.

4

Modulation of Mdm2 expression and p53-induced apoptosis in immortalized human ovarian granulosa cells.

Hosokawa K, Aharoni D, Dantes A, Shaulian E, Schere-Levy C, Atzmon R, Kotsuji F, Oren M, Vlodavsky I, Amsterdam A. Hosokawa K, et al. Among authors: kotsuji f. Endocrinology. 1998 Nov;139(11):4688-700. doi: 10.1210/endo.139.11.6280. Endocrinology. 1998. PMID: 9794481

5

Role of laminin in ovarian cancer tumor growth and metastasis via regulation of Mdm2 and Bcl-2 expression.

Yoshida Y, Hosokawa K, Dantes A, Kotsuji F, Kleinman HK, Amsterdam A. Yoshida Y, et al. Among authors: kotsuji f. Int J Oncol. 2001 May;18(5):913-21. doi: 10.3892/ijo.18.5.913. Int J Oncol. 2001. PMID: 11295035

6

Establishment of FSH-responsive cell lines by transfection of pre-ovulatory human granulosa cells with mutated p53 (p53val135) and Ha-ras genes.

Tajima K, Hosokawa K, Yoshida Y, Dantes A, Sasson R, Kotsuji F, Amsterdam A. Tajima K, et al. Among authors: kotsuji f. Mol Hum Reprod. 2002 Jan;8(1):48-57. doi: 10.1093/molehr/8.1.48. Mol Hum Reprod. 2002. PMID: 11756569

7

Establishment of a novel human ovarian cancer cell line with high anchorage-independent growth ability.

Nishikawa Y, Yoshida Y, Kawahara K, Kurokawa T, Tajima K, Kotsuji F. Nishikawa Y, et al. Among authors: kotsuji f. Int J Oncol. 2003 Dec;23(6):1679-86. doi: 10.3892/ijo.23.6.1679. Int J Oncol. 2003. PMID: 14612941

8

The potent peptide antagonist to angiogenesis, C16Y, and cisplatin act synergistically in the down-regulation of the Bcl-2/Bax ratio and the induction of apoptosis in human ovarian cancer cells.

Shinagawa A, Yoshida Y, Kurokawa T, Horiuchi Y, Tsuyoshi H, Orisaka M, Sawamura Y, Kleinman HK, Kotsuji F. Shinagawa A, et al. Among authors: kotsuji f. Int J Oncol. 2011 Dec;39(6):1359-64. doi: 10.3892/ijo.2011.1134. Epub 2011 Jul 20. Int J Oncol. 2011. PMID: 21935568

9

Down-regulation of steroidogenic response to gonadotropins in human and rat preovulatory granulosa cells involves mitogen-activated protein kinase activation and modulation of DAX-1 and steroidogenic factor-1.

Tajima K, Dantes A, Yao Z, Sorokina K, Kotsuji F, Seger R, Amsterdam A. Tajima K, et al. Among authors: kotsuji f. J Clin Endocrinol Metab. 2003 May;88(5):2288-99. doi: 10.1210/jc.2002-020913. J Clin Endocrinol Metab. 2003. PMID: 12727988

10

Induction of Ad4BP/SF-1, steroidogenic acute regulatory protein, and cytochrome P450scc enzyme system expression in newly established human granulosa cell lines.

Hosokawa K, Dantes A, Schere-Levy C, Barash A, Yoshida Y, Kotsuji F, Vlodavsky I, Amsterdam A. Hosokawa K, et al. Among authors: kotsuji f. Endocrinology. 1998 Nov;139(11):4679-87. doi: 10.1210/endo.139.11.6279. Endocrinology. 1998. PMID: 9794480

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page